ArticleCell death & disease2026

Targeting GNG4 inhibits tumor progression and restores enzalutamide sensitivity in prostate cancer by suppressing autophagy.

Lei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.